States

Latest KFF Health News Stories

High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment

KFF Health News Original

The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.

Personas de bajos ingresos no pueden recibir terapias efectivas contra la diabetes por el alto costo

KFF Health News Original

La escasez de suministros y las barreras que ponen las aseguradoras para obtener esta poderosa clase de medicamentos, llamados agonistas de GLP-1, han dejado a muchas personas que viven con diabetes y obesidad sin los medicamentos que necesitan para mantenerse saludables.

Medicaid Unwinding Deals Blow to Tenuous System of Care for Native Americans

KFF Health News Original

Although Native American and Alaska Native adults are enrolled in Medicaid at higher rates than their white counterparts, many tribal leaders feel they’ve been left in the dark as states roll through the tumultuous Medicaid unwinding that started last year.

The Lure of Specialty Medicine Pulls Nurse Practitioners From Primary Care

KFF Health News Original

Nurse practitioners have been viewed as a key to addressing the shortage of primary care physicians. But data suggests that, just like doctors, they are increasingly drawn to better-paying specialties.

Clean Needles Save Lives. In Some States, They Might Not Be Legal.

KFF Health News Original

As billions of dollars from settlements with opioid manufacturers and distributors go to state and local governments, efforts to reduce the epidemic’s harm can be hamstrung by drug paraphernalia laws. Health authorities say distributing clean syringes to users can save lives, but in states like Pennsylvania, it may be illegal.

California’s $12 Billion Medicaid Makeover Banks on Nonprofits’ Buy-In

KFF Health News Original

California’s Medicaid program is relying heavily on community groups to deliver new social services to vulnerable patients, such as security deposits for homeless people and air purifiers for asthma patients. But many of these nonprofits face staffing and billing challenges and haven’t been able to deliver services effectively.

Addiction Treatment Homes Say Montana’s Funding Fixes Don’t Go Far Enough

KFF Health News Original

Montana has created a voucher program to help cover room and board costs at low-intensity residential programs for people with addiction. Those running the homes say bridging that care is urgent but that the program’s funding falls far below the need.

Federal Panel Prescribes New Mental Health Strategy To Curb Maternal Deaths

KFF Health News Original

The leading causes of pregnancy-related deaths in the United States — including suicides and fatalities linked to substance use disorders — stem from mental health conditions. Now a federal task force has recommended strategies to help women who are at risk during or after pregnancy.

Medics at UCLA Protest Say Police Weapons Drew Blood and Cracked Bones

KFF Health News Original

In contrast to police statements, volunteer medics said they treated serious wounds as UCLA’s pro-Palestinian protest was besieged by police and counterprotesters, including some injuries that appeared to be caused by “less lethal” projectiles fired by cops.

Médicos que atendieron a manifestantes en la protesta estudiantil en la UCLA dicen que la policía dejó huesos rotos y hemorragias

KFF Health News Original

La protesta de la UCLA, que reunió a miles de personas que se oponen a los continuos bombardeos de Israel sobre la Franja de Gaza, comenzó en abril y alcanzó un peligroso crescendo en mayo, cuando manifestantes pro Israel y la policía se enfrentaron a los activistas y a los que los apoyaban.

The Psychedelics-As-Medicine Movement Spreads to California

KFF Health News Original

Ecstasy, “magic mushrooms” and other psychedelic drugs could soon be recognized as therapeutic in California — one of the latest states, and the biggest, to consider allowing their use as medicine. Legislation by state Sen. Scott Wiener (D) and Assembly member Marie Waldron (R) would allow the therapeutic use of psilocybin, mescaline, ecstasy and dimethyltryptamine […]

Tribal Nations Invest Opioid Settlement Funds in Traditional Healing To Treat Addiction

KFF Health News Original

Hundreds of Native American tribes are getting money from settlements with companies that made or sold prescription painkillers. Some are investing it in sweat lodges, statistical models, and insurance-billing staffers.

After a Child’s Death, California Weighs Rules for Phys Ed During Extreme Weather

KFF Health News Original

A California lawmaker wants the state to craft guidelines for how and when schoolchildren can play or exercise during extreme weather, including heat waves. The bill comes after a 12-year-old boy died after a physical education instructor told him to run as the temperature topped 90 degrees.

Medicaid ‘Unwinding’ Decried as Biased Against Disabled People

KFF Health News Original

People with disabilities say they are abruptly losing their Medicaid home health benefits and are being advised incorrectly when they call state offices for more information. “Every day the anxiety builds,” one beneficiary told KFF Health News.

Abortion Bans Are Repelling the Nation’s Future Doctors

KFF Health News Original

Ash Panakam is about to graduate from Harvard Medical School. She’s from Georgia and always assumed she would return to the South for her residency. But the Supreme Court’s 2022 decision overturning the nationwide right to abortion changed everything. “Ultimately I shifted my selection pretty drastically,” she said. “I was struggling to find a residency […]

FDA Said It Never Inspected Dental Lab That Made Controversial AGGA Device

KFF Health News Original

Johns Dental Laboratories stopped making the Anterior Growth Guidance Appliance last year after a KFF Health News-CBS News investigation into allegations of patient harm. The company had “never” reported any complaints about its products to the FDA, according to the agency.